Correlation Between Tissue Regenix and Eastman Chemical

Can any of the company-specific risk be diversified away by investing in both Tissue Regenix and Eastman Chemical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tissue Regenix and Eastman Chemical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tissue Regenix Group and Eastman Chemical Co, you can compare the effects of market volatilities on Tissue Regenix and Eastman Chemical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tissue Regenix with a short position of Eastman Chemical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tissue Regenix and Eastman Chemical.

Diversification Opportunities for Tissue Regenix and Eastman Chemical

-0.61

Correlation Coefficient

Tissue Regenix  Eastman Chemical

Excellent diversification

The 3 months correlation between Tissue and Eastman is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Tissue Regenix Group and Eastman Chemical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eastman Chemical and Tissue Regenix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tissue Regenix Group are associated (or correlated) with Eastman Chemical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eastman Chemical has no effect on the direction of Tissue Regenix i.e., Tissue Regenix and Eastman Chemical go up and down completely randomly.

Pair Corralation between Tissue Regenix and Eastman Chemical

Assuming the 90 days trading horizon Tissue Regenix Group is expected to under-perform the Eastman Chemical. In addition to that, Tissue Regenix is 1.05 times more volatile than Eastman Chemical Co. It trades about -0.01 of its total potential returns per unit of risk. Eastman Chemical Co is currently generating about 0.02 per unit of volatility. If you would invest  8,109  in Eastman Chemical Co on October 10, 2024 and sell it today you would earn a total of  827.00  from holding Eastman Chemical Co or generate 10.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	90.95%
Values	Daily Returns

Tissue Regenix Group  vs.  Eastman Chemical Co

Tissue Regenix Group

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Tissue Regenix Group are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Tissue Regenix may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Eastman Chemical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eastman Chemical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Tissue Regenix and Eastman Chemical

The main advantage of trading using opposite Tissue Regenix and Eastman Chemical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tissue Regenix position performs unexpectedly, Eastman Chemical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eastman Chemical will offset losses from the drop in Eastman Chemical's long position.

The idea behind Tissue Regenix Group and Eastman Chemical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.